Key facts
- Notable investors include Northern Light Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Qiushengyuan Biopharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Qiushengyuan Biopharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qiushengyuan Biopharmaceutical
Provider of biopharmaceutical technology services designed for medical research and production purposes. The company offers capabilities in efficient process development, precise analytical testing, and quality control integration, enabling pharmaceutical and healthcare markets to improve reliability, accelerate development timelines, enhance compliance with regulatory standards, and strengthen overall competitiveness through advanced technical support and specialized expertise.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Qiushengyuan Biopharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qiushengyuan Biopharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qiushengyuan Biopharmaceutical in its N-PORT filings yet. We sweep new filings monthly.